During the past decade, Bethesda Diabetes Research Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bethesda Diabetes Research Center" #1 sponsor was "Abbott Diabetes Care" with 1 trials, followed by "Amgen" with 1 trials sponsored, "Medtronic Diabetes" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored and "The Medicines Company" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Bethesda Diabetes Research Center" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials), "Coronary Heart Disease (CHD)" (1 trials), "Diabetes" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Bethesda Diabetes Research Center" in a lesser frequency.

Most popular intervention types in "Bethesda Diabetes Research Center" are "Drug" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Evolocumab" (2 trials), "ALN-PCSSC" (1 trials), "Inclisiran" (1 trials), "Insulin Pump (Medtronic Minimed Paradigm® VEO)" (1 trials) and "Normal Saline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Bethesda Diabetes Research Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Bethesda Diabetes Research Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Bethesda Diabetes Research Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Bethesda Diabetes Research Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".